Activation of the carboxypeptidase U (CPU, TAFIa, CPB2) system in patients with SARS-CoV-2 infection could contribute to COVID-19 hypofibrinolytic state and disease severity prognosis

Bron
2022,
Auteur(s)

Profiling of proteases as potential therapeutic targets : focus on inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS)

Bron
Antwerpen, Universiteit Antwerpen, Faculteit Farmaceutische, Biomedische en Diergeneeskundige Wetenschappen, Departement Farmaceutische Wetenschappen, 2022,ix, 259 p.